Author

Ling-Xiao Wang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Effectiveness and Safety of Fixed‐Dose Combination Metformin and Empagliflozin in Type 2 Diabetes: A Prospective, Multicenter, Real‐World Study From China

This study assessed the real‐world effectiveness and safety of a fixed‐dose combination (FDC) of metformin and empagliflozin in Chinese patients with type 2 diabetes mellitus (T2DM).

Wei-Jian Ke, Ying-Hong Kong, Song-Bo Fu et al. · Journal of Diabetes · 0 citations

Open access Oct 2026

N6 ‐Methyladenosine Demethylase FTO Protects Pancreatic ΒTC6 Cells From Cholesterol‐Triggered Damage by Regulating Nfatc4: Insights From RNA‐Seq Analysis

ABSTRACT Excessive cholesterol contributes to pancreatic β‐cell dysfunction and plays a critical role in the pathogenesis of metabolic disorders. FTO is a well‐characterized N6‐methyladenosine (m6A) demethylase involved in the regulation of RNA metabolism; however, its role in pancreatic β‐cells under cholesterol‐induc...

Ping-Ping Hong, Yong-Jie Li, Jian-Dong Lin et al. · Chemical Biology and Drug De... · 0 citations